Information  X 
Enter a valid email address

Savills PLC (SVS)

  Print      Mail a friend       Annual reports

Tuesday 16 April, 2019

Savills PLC

Director/PDMR Shareholding

RNS Number : 3783W
Savills PLC
16 April 2019
 

SAVILLS PLC (THE 'COMPANY')

NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS

 

Grant of Share Awards

 

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and other persons discharging managerial responsibilities ('PDMR') as follows:-

 

Director/ PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR on
15 April 2019

Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan

Mark Ridley (Director)

39,673

134,119

Simon Shaw (Director)

59,182

158,540

Simon Hope (PDMR)

5,449

19,587

Chris Lee (PDMR)

12,643

37,008

Christian Mancini (PDMR)

9,940

26,403

James Sparrow (PDMR)

26,594

44,375

 

The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under The Schedule to The Savills Deferred Share Bonus Plan to PDMRs based in the United States of America as follows:-

 

PDMR

Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the PDMR on
15 April 2019

Resulting beneficial interest under the Savills Deferred Share Bonus Plan

Mitchell Steir (PDMR)

17,190

34,588

All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.

The Company announces that on 15 April 2019 awards have been made under The Savills plc Performance Share Plan (the 'Performance Share Plan') to Directors and PDMRS as follows:- 

 

Director/ PDMR

Number of shares subject to the Performance Share Plan awarded to the Director / PDMR on 15 April 2019

Total number of shares subject to Performance Share Plan Awards following this notification

Mark Ridley (Director)

62,997

161,579

Simon Shaw (Director)

48,174

149,835

Chris Lee (PDMR)

24,523

65,708

The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.

Awards of shares are made subject to a three-year performance period.  Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period for Directors.

Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:

(a) 50% of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);

(b) the other 50% of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance.

Awards vest as follows:

(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points; and

(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points.

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the person discharging managerial responsibilities/ person closely associated

 

(a)

Name

1.    Mark Ridley

2.    Simon Shaw

3.    Simon Hope

4.    Chris Lee

5.    Christian Mancini

6.    James Sparrow

7.    Mitchell Steir

 

2.

Reason for the notification

 

(a)

Position/ status

1.    Group Chief Executive/ Director

2.    Group Chief Financial Officer/ Director

3.    Global Head of Capital Markets/ PDMR

4.    Group Legal Director and Company Secretary/ PDMR

5.    Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR

6.    Chief Executive Officer UK & EMEA/ PDMR

7.    Chairman and CEO - Savills North America/ PDMR

 

(b)

Initial notification/ Amendment

 

Initial notification

3.

Details of the issuer

 

(a)

Name

Savills plc

 

(b)

LEI

213800WXICGMBWHTA933

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

(a)

Description of the Financial Instrument

 

Awards over Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

 

GB00B135BJ46

(c)

Nature of the transaction

 

Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP') and Performance Share Plan ('PSP')

 

(d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£nil per share

 

1.    39,673 (DSBP) & 62,997 (PSP)

2.    59,182 (DSBP) & 48,174 (PSP)

3.    5,449 (DSBP)

4.    12,643 (DSBP) & 24,523 (PSP)

5.    9,940 (DSBP)

6.    26,594 (DSBP)

7.    17,190 (DSBP)

 

(e)

Aggregated information

 

-      Aggregated volume

-      Price

 

N/A

 

 

(f)

Date of the transaction

 

15 April 2019

(g)

Place of the transaction

 

Outside a trading venue

 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

 

16 April 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKMGMDMVMGLZM

a d v e r t i s e m e n t